Ajanta Pharma Ltd. Investor Presentation

Ajanta Pharma Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

announcement
Conference/Earnings Calls Alerts
2602.25
0.99%
Investor Presentation
BSE India
Pursuant to Regulation 46 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are now attaching the presentation on results being circulated to the investors and analysts and uploaded on our website.
2602.25
0.99%
2602.25
0.99%
Investor Presentation
BSE India
Ajanta Pharma Ltd has submitted to BSE a copy of Investor Presentation for the period ended September 30, 2016
2602.25
0.99%
2602.25
0.99%
2602.25
0.99%
Investor Presentation
BSE India
Ajanta Pharma Ltd has submitted to BSE a copy of Investor Presentation - Q3 FY16

No results found